APOTEX INC FDA Approval ANDA 091072

ANDA 091072

APOTEX INC

FDA Drug Application

Application #091072

Application Sponsors

ANDA 091072APOTEX INC

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001CAPSULE;ORALEQ 1.5MG BASE0RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
002CAPSULE;ORALEQ 3MG BASE0RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
003CAPSULE;ORALEQ 4.5MG BASE0RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE
004CAPSULE;ORALEQ 6MG BASE0RIVASTIGMINE TARTRATERIVASTIGMINE TARTRATE

FDA Submissions

ORIG1AP2013-05-16
LABELING; LabelingSUPPL2AP2015-07-21STANDARD
LABELING; LabelingSUPPL6AP2015-07-21STANDARD
LABELING; LabelingSUPPL7AP2019-07-17STANDARD
LABELING; LabelingSUPPL8AP2019-07-17STANDARD

Submissions Property Types

ORIG1Null17
SUPPL2Null7
SUPPL6Null7
SUPPL7Null15
SUPPL8Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91072
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RIVASTIGMINE TARTRATE","activeIngredients":"RIVASTIGMINE TARTRATE","strength":"EQ 1.5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RIVASTIGMINE TARTRATE","activeIngredients":"RIVASTIGMINE TARTRATE","strength":"EQ 3MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RIVASTIGMINE TARTRATE","activeIngredients":"RIVASTIGMINE TARTRATE","strength":"EQ 4.5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RIVASTIGMINE TARTRATE","activeIngredients":"RIVASTIGMINE TARTRATE","strength":"EQ 6MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RIVASTIGMINE TARTRATE","submission":"RIVASTIGMINE TARTRATE","actionType":"EQ 1.5MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RIVASTIGMINE TARTRATE","submission":"RIVASTIGMINE TARTRATE","actionType":"EQ 3MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RIVASTIGMINE TARTRATE","submission":"RIVASTIGMINE TARTRATE","actionType":"EQ 4.5MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RIVASTIGMINE TARTRATE","submission":"RIVASTIGMINE TARTRATE","actionType":"EQ 6MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.